# OnCo record dzd8586 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/dzd8586/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "dzd8586" ;
  schema:name "DZD8586"@en ;
  schema:alternateName "Birelentinib"@en ;
  schema:description "DZD8586 is an experimental small-molecule drug from Dizal Pharmaceuticals in phase 3 trials for chronic lymphocytic leukaemia and diffuse large B-cell lymphoma, with its target not yet stated publicly."@en ;
  schema:url <https://onco.cc/drugs/dzd8586/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=DZD8586>, <https://www.dizalpharma.com> ;
  onco:status "phase-3" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "small molecule" ;
  onco:cancers <https://onco.cc/cancers/cll/>, <https://onco.cc/cancers/dlbcl/> ;
  onco:companies <https://onco.cc/companies/dizal/> ;
  onco:trials <https://onco.cc/trials/tai-shan6/>, <https://onco.cc/trials/nct07059650/>, <https://onco.cc/trials/nct07154264/>, <https://onco.cc/trials/nct06539182/> .